AVITA MEDICAL WKN: A0Q40S ISIN: AU000000AVH4 Kürzel: AVMXF Forum: Aktien Thema: Hauptdiskussion

investing

https://m.investing.com/news/btig-stick-to-their-buy-rating-for-avita-medical-2224313

https://ir.avitamedical.com/node/7331/html

https://pub.webull.com/us/news-html/fea56d6653864f26add86128bf7cbb9b.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en AVITA Therapeutics Sees Prelim. Q4 RECELL System Sales $3.79M, Total Net Revenue $3.88M

https://ktvo.com/news/focus-on-your-health/spray-on-skin-helps-firefighter-heal-faster-after-burn ... Spray-on skin, or ReCell, involves taking a section of healthy skin — an amount that is far smaller than what is needed for a standard graft — and scraping of the healthy skin cells after mixing them with an enzyme solution. The process takes about a half-hour. That mixture is then sprayed on the burn, and a fresh layer of healthy skin starts to grow. “The biggest downside of burn surgery and skin graft surgery, since we’ve started doing it decades ago, is that there is no way to do it without creating another wound that the patient needs to heal from,” Litt said. “Using spray-on skin dramatically reduces the size of a wound we need to create. You can do it fairly quickly, and it allows us to get wounds to heal up sooner than we otherwise would have.” ...

Bei mir nicht

Gibts was neues zum Kurs und zum Handel?

https://www.eurekareport.com.au/investment-news/avita-therapeutics-makes-a-splash-in-the-us/147693

Der aktuelle Kurs wäre schon mal interessant

Hallo ich habe gerade mit meinem Broker telefoniert, also es liegt an der Lagerstelle in der USA die haben anscheinend Probleme. Er konnte aber zur Abwicklung und den Problemen nichts sagen nur "ABWARTEN" ist angesagt

Echt beschissen, dass man so wenig Informationen bekommt

Wann stellt die diba endlich richtig um?

Für mich heißt es, dass ich kein Stück hergeben mag 🍀

Was heißt das jetzt?

Oppenheimer analyst Kevin DeGeeter maintained a Buy rating on Avita Medical (NASDAQ:RCEL) on Monday, setting a price target of $45, which is approximately 50.00% above the present share price of $30. DeGeeter expects Avita Medical to post earnings per share (EPS) of $ for the third quarter of 2020. The current consensus among 2 TipRanks analysts is for a Moderate Buy rating of shares in Avita Medical, with an average price target of $42.5. The analysts price targets range from a high of $45 to a low of $40.